Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis 03.07.2011 | Nachricht | finanzen.net

Links shared publicly online about this topic.

  • 173
    total visits

Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis 03.07.2011 | Nachricht | finanzen.net

finanzen.net —

Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation as Potential Therapeutic Option for Treatment of Multiple Sclerosis 03.07.2011 | Nachricht | finanzen.net

View full resource at finanzen.net

Tags: Multiple Sclerosis, Biogen Idec

  • Share

Most Recently Shared on July 3, 2011 at 9:56 pm By:

MS_Wisdom2 OrganizedWisdom MS

Biogen Idec Researchers Identify Novel Approach for Promoting Remyelination and Inhibiting Autoimmune Activation... http://bit.ly/k3FOM9

10 months ago...

Reply

Retweet

Favorite

Advertisement